ARTZAL
Report
- Report Number
- 9612392-2010-00003
- Event Type
- Injury
- Date Received
- April 26, 2010
- Date of Event
- August 30, 2009
- Report Date
- April 26, 2010
- Manufacturer
- SEIKAGAKU CORP
- Product Code
- MOZ
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
ADDITIONAL IMPLANT DATES: (B) (6) 2009, (B) (6) 2009. THIS IS A CONSUMER'S REPORT FROM (B) (6) THROUGH THE SALES PARTNER, AND A DEFINITIVE REPORT. THIS IS A SPONTANEOUS REPORT FROM A PT. NO ADDITIONAL INFO FROM THE PHYSICIAN IS AVAILABLE. OUR MEDICAL ADVISER'S COMMENT: THIS CAUSE OF THE FACIAL PARALYSIS REMAINS UNCLEAR BASED ON SEVERAL TESTS INCLUDING BORRELIA. IT WOULD BE CONSIDERED ACCIDENTAL SYMPTOMS. GENERALLY, IT IS DIFFICULT TO SPECIFY THE CAUSE OF THE FACIAL PARALYSIS, WHICH IS NOT INDUCED BY PHARMACEUTICALS, AND THIS IS THE FIRST CASE IN THE MARKET EXPERIENCE OF ARTZAL. THEREFORE, THIS CASE IS UNLIKELY TO RELATE TO ARTZAL INJECTION.
ADVERSE EVENT: FACIAL PARALYSIS, FEVER, FATIGUE. ON 2009 (B) (6) - A FEMALE PT RECEIVED ARTZAL INJECTIONS IN BOTH KNEES FOR OSTEOARTHRITIS. ON 2009 (B) (6) - SHE RECEIVED 2ND ARTZAL INJECTIONS IN BOTH KNEES. ON 2009 (B) (6) - SHE RECEIVED 3RD ARTZAL INJECTIONS IN BOTH KNEES. ON 2009 (B) (6) - A FEW DAYS LATER, SHE FELT FEVERISH. SHE WAS HOSPITALIZED SINCE THE MOUTH WAS HANGING AND THE EYE FELT STRANGE. A BLOOD CLOT WAS SUSPECTED SINCE SHE PREVIOUSLY HAD HAD ONE. ON 2009 (B) (6) - AFTER APPROXIMATELY 24 HRS AFTER THE HOSPITALIZATION, SHE RECEIVED THE DIAGNOSIS FACIAL PARALYSIS AND TREATMENT WITH CORTISON WAS INITIATED. ON 2009(B) (6) - SHE IS STILL BEING CHECKED UP AT EYE CLINIC AND EAR, NOSE THROAT AND HAS STILL FEVER. THE FEVER DAILY VARIES BETWEEN 37.6-38.8 DEGREES CELSIUS STILL AFTER A MONTH. THE PHYSICIAN HAS TAKEN SEVERAL SAMPLES (E.G BORRELIA), BUT STILL NO EXPLANATION TO THE FEVER. THE PT MUST ALSO USE OINTMENT FOR THE EYE EVERY DAY AND A MOIST CHAMBER SINCE SHE CAN'T BLINK. THE SKEWNESS OF THE MOUTH IS IMPROVING. THE PT CANNOT WORK DUE TO THE FATIGUE AND EYE PROBLEM. NO FURTHER INFO IS CURRENTLY AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ARTZAL | SODIUM HYALURONATE | MOZ | SEIKAGAKU CORP | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization | GLUCOSINE (GLUCOSAMINE) - UNK| TROMBYL (ASPIRIN) - 160MG| SIMVASTATIN - 20MG| NEXIUM ENTEROTABLETS (ESOMEPRAZOLE) - 40MG| LASIX RETARD (FUROSEMIDE) - 30MG| ENALAPRIL ACTAVIS TABLETS - 10MG |